

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 9.12558389 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 8.22619245 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.22619245 |
| 4 | glyoxylate metabolic process (GO:0046487) | 8.01272278 |
| 5 | regulation of protein activation cascade (GO:2000257) | 7.93585136 |
| 6 | regulation of fibrinolysis (GO:0051917) | 7.85329930 |
| 7 | ethanol oxidation (GO:0006069) | 7.60340053 |
| 8 | regulation of complement activation (GO:0030449) | 7.58562588 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.43644551 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 7.43644551 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 7.04483106 |
| 12 | drug metabolic process (GO:0017144) | 6.81647331 |
| 13 | urea metabolic process (GO:0019627) | 6.74805351 |
| 14 | oxidative demethylation (GO:0070989) | 6.53748079 |
| 15 | imidazole-containing compound metabolic process (GO:0052803) | 6.42534941 |
| 16 | protein carboxylation (GO:0018214) | 6.32644355 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.32644355 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 6.25639911 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 6.11170236 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 6.09884085 |
| 21 | ethanol metabolic process (GO:0006067) | 6.04850396 |
| 22 | fibrinolysis (GO:0042730) | 5.98033772 |
| 23 | bile acid biosynthetic process (GO:0006699) | 5.90239407 |
| 24 | blood coagulation, intrinsic pathway (GO:0007597) | 5.84126763 |
| 25 | urea cycle (GO:0000050) | 5.73749987 |
| 26 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.64877760 |
| 27 | protein activation cascade (GO:0072376) | 5.47804429 |
| 28 | cellular glucuronidation (GO:0052695) | 5.45920577 |
| 29 | opsonization (GO:0008228) | 5.44762210 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 5.38249156 |
| 31 | complement activation (GO:0006956) | 5.32554998 |
| 32 | complement activation, classical pathway (GO:0006958) | 5.22781426 |
| 33 | bile acid metabolic process (GO:0008206) | 5.20336500 |
| 34 | uronic acid metabolic process (GO:0006063) | 5.15878743 |
| 35 | glucuronate metabolic process (GO:0019585) | 5.15878743 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 5.14190418 |
| 37 | tyrosine metabolic process (GO:0006570) | 5.07767551 |
| 38 | glycine metabolic process (GO:0006544) | 5.07599492 |
| 39 | negative regulation of cholesterol transport (GO:0032375) | 5.01298104 |
| 40 | negative regulation of sterol transport (GO:0032372) | 5.01298104 |
| 41 | regulation of plasminogen activation (GO:0010755) | 4.92797558 |
| 42 | S-adenosylmethionine metabolic process (GO:0046500) | 4.90225455 |
| 43 | bile acid and bile salt transport (GO:0015721) | 4.88465822 |
| 44 | regulation of humoral immune response (GO:0002920) | 4.80924334 |
| 45 | glutamate metabolic process (GO:0006536) | 4.76693277 |
| 46 | negative regulation of protein activation cascade (GO:2000258) | 4.75718398 |
| 47 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.74229089 |
| 48 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.74229089 |
| 49 | cytolysis (GO:0019835) | 4.60588947 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 4.50547171 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 4.50547171 |
| 52 | tryptophan catabolic process (GO:0006569) | 4.50547171 |
| 53 | alkaloid metabolic process (GO:0009820) | 4.48886556 |
| 54 | acute-phase response (GO:0006953) | 4.46798038 |
| 55 | negative regulation of hemostasis (GO:1900047) | 4.44495008 |
| 56 | negative regulation of blood coagulation (GO:0030195) | 4.44495008 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.33252411 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.33252411 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.31695180 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.31695180 |
| 61 | alpha-amino acid catabolic process (GO:1901606) | 4.29505451 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 4.12227848 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 4.03548710 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.03222305 |
| 65 | negative regulation of coagulation (GO:0050819) | 4.03045147 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 4.01041517 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 4.01041517 |
| 68 | macromolecular complex remodeling (GO:0034367) | 4.01041517 |
| 69 | negative regulation of wound healing (GO:0061045) | 3.98694766 |
| 70 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.96733636 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.93927757 |
| 72 | negative regulation of complement activation (GO:0045916) | 3.93023291 |
| 73 | flavonoid metabolic process (GO:0009812) | 3.91036623 |
| 74 | tryptophan metabolic process (GO:0006568) | 3.80846220 |
| 75 | arginine metabolic process (GO:0006525) | 3.80596982 |
| 76 | positive regulation of hemostasis (GO:1900048) | 3.78397670 |
| 77 | positive regulation of blood coagulation (GO:0030194) | 3.78397670 |
| 78 | cholesterol efflux (GO:0033344) | 3.75083650 |
| 79 | intestinal cholesterol absorption (GO:0030299) | 3.72677298 |
| 80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.66582253 |
| 81 | sodium-independent organic anion transport (GO:0043252) | 3.65713424 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.65163617 |
| 83 | xenobiotic metabolic process (GO:0006805) | 3.57527705 |
| 84 | hormone catabolic process (GO:0042447) | 3.57255953 |
| 85 | ketone body metabolic process (GO:1902224) | 3.53102390 |
| 86 | response to mercury ion (GO:0046689) | 3.51307470 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.46001213 |
| 88 | positive regulation of coagulation (GO:0050820) | 3.45898025 |
| 89 | reverse cholesterol transport (GO:0043691) | 3.43737075 |
| 90 | oxaloacetate metabolic process (GO:0006107) | 3.43227958 |
| 91 | phospholipid efflux (GO:0033700) | 3.43204170 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.35763755 |
| 93 | regulation of acute inflammatory response (GO:0002673) | 3.35167243 |
| 94 | cysteine metabolic process (GO:0006534) | 3.34428937 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.32873085 |
| 96 | regulation of apoptotic cell clearance (GO:2000425) | 3.31352135 |
| 97 | exogenous drug catabolic process (GO:0042738) | 10.9081825 |
| 98 | omega-hydroxylase P450 pathway (GO:0097267) | 10.8895569 |
| 99 | epoxygenase P450 pathway (GO:0019373) | 10.6564465 |
| 100 | drug catabolic process (GO:0042737) | 10.1567879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.78317436 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50229204 |
| 3 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.59490702 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.57678415 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.42879501 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.25778105 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06424703 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.88978216 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.46745166 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08936940 |
| 11 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.05964998 |
| 12 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.00410567 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6242501 |
| 14 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.97570106 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.73481405 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.63451239 |
| 17 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.54221967 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50774241 |
| 19 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47404572 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44929909 |
| 21 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23486989 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22721096 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13894604 |
| 24 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12539464 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08813714 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04723854 |
| 27 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03852661 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02455039 |
| 29 | CBP_21632823_ChIP-Seq_H3396_Human | 1.01898048 |
| 30 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01577304 |
| 31 | NFYA_21822215_ChIP-Seq_K562_Human | 0.99496603 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97922882 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97427096 |
| 34 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96195415 |
| 35 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95827791 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95607963 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.94828812 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93907989 |
| 39 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93859563 |
| 40 | AR_20517297_ChIP-Seq_VCAP_Human | 0.93770706 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92486234 |
| 42 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92437881 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90741326 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90067601 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85013944 |
| 46 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84488847 |
| 47 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81972914 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.79821788 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.79685839 |
| 50 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76775689 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75622771 |
| 52 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.75338801 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75120884 |
| 54 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.73810565 |
| 55 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.73456499 |
| 56 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73038830 |
| 57 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.72776354 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.72417543 |
| 59 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.72325126 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.71724257 |
| 61 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71576688 |
| 62 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.70786113 |
| 63 | NFYB_21822215_ChIP-Seq_K562_Human | 0.70765894 |
| 64 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.69573061 |
| 65 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.68959434 |
| 66 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.67281914 |
| 67 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66835964 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.66678306 |
| 69 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.66152668 |
| 70 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.66122483 |
| 71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.66000351 |
| 72 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.65602906 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.65264117 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 0.64392742 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.63046663 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.63035183 |
| 77 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62961829 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62707211 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62707211 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.62337872 |
| 81 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.61506746 |
| 82 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.61011857 |
| 83 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.60362772 |
| 84 | TBL1_22424771_ChIP-Seq_293T_Human | 0.60309359 |
| 85 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.60238502 |
| 86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.60238502 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.59228072 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58540428 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.58289993 |
| 90 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.58081377 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.57754470 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.57565900 |
| 93 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.57087143 |
| 94 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.57043105 |
| 95 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.55901998 |
| 96 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.55601724 |
| 97 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.55542112 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.55445265 |
| 99 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.54671634 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.54619360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.77391238 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 6.41495765 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.31211015 |
| 4 | MP0005360_urolithiasis | 5.93488624 |
| 5 | MP0005365_abnormal_bile_salt | 5.33718352 |
| 6 | MP0003195_calcinosis | 5.26821580 |
| 7 | MP0003252_abnormal_bile_duct | 4.39022238 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 4.37220076 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.25446377 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.93795710 |
| 11 | MP0003868_abnormal_feces_composition | 2.72997511 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.58868399 |
| 13 | MP0005332_abnormal_amino_acid | 2.38482127 |
| 14 | MP0009697_abnormal_copulation | 2.38020393 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.35071367 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.09216157 |
| 17 | MP0000609_abnormal_liver_physiology | 1.82984689 |
| 18 | MP0005670_abnormal_white_adipose | 1.70698021 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.69757312 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.68911454 |
| 21 | MP0001661_extended_life_span | 1.53746970 |
| 22 | MP0009840_abnormal_foam_cell | 1.46276271 |
| 23 | MP0001764_abnormal_homeostasis | 1.46057356 |
| 24 | MP0009053_abnormal_anal_canal | 1.41422932 |
| 25 | MP0002132_abnormal_respiratory_system | 1.27036272 |
| 26 | MP0002282_abnormal_trachea_morphology | 1.23205964 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.23049586 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.15493784 |
| 29 | MP0002249_abnormal_larynx_morphology | 1.12243908 |
| 30 | MP0005408_hypopigmentation | 1.11410832 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.09126834 |
| 32 | MP0000598_abnormal_liver_morphology | 1.05949302 |
| 33 | MP0009764_decreased_sensitivity_to | 1.05724824 |
| 34 | MP0008872_abnormal_physiological_respon | 1.04846767 |
| 35 | MP0003879_abnormal_hair_cell | 0.96429714 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91815489 |
| 37 | MP0009643_abnormal_urine_homeostasis | 0.89635036 |
| 38 | MP0009763_increased_sensitivity_to | 0.86289385 |
| 39 | MP0002971_abnormal_brown_adipose | 0.84643003 |
| 40 | MP0005187_abnormal_penis_morphology | 0.81945631 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.81517293 |
| 42 | MP0001915_intracranial_hemorrhage | 0.77336094 |
| 43 | MP0005376_homeostasis/metabolism_phenot | 0.77247371 |
| 44 | MP0005266_abnormal_metabolism | 0.74141039 |
| 45 | MP0008469_abnormal_protein_level | 0.72285792 |
| 46 | MP0005535_abnormal_body_temperature | 0.71408559 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 0.70777077 |
| 48 | MP0002168_other_aberrant_phenotype | 0.70520728 |
| 49 | MP0005395_other_phenotype | 0.68937547 |
| 50 | MP0002332_abnormal_exercise_endurance | 0.66619301 |
| 51 | MP0004130_abnormal_muscle_cell | 0.65280093 |
| 52 | MP0004782_abnormal_surfactant_physiolog | 0.63295276 |
| 53 | MP0003690_abnormal_glial_cell | 0.62795435 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 0.61103459 |
| 55 | MP0000604_amyloidosis | 0.60839286 |
| 56 | MP0008874_decreased_physiological_sensi | 0.60524432 |
| 57 | MP0005334_abnormal_fat_pad | 0.59935145 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.58819758 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 0.52135219 |
| 60 | MP0005464_abnormal_platelet_physiology | 0.51139202 |
| 61 | MP0003186_abnormal_redox_activity | 0.49843479 |
| 62 | MP0005377_hearing/vestibular/ear_phenot | 0.49626917 |
| 63 | MP0003878_abnormal_ear_physiology | 0.49626917 |
| 64 | MP0005451_abnormal_body_composition | 0.48721976 |
| 65 | MP0005023_abnormal_wound_healing | 0.47650012 |
| 66 | MP0009785_altered_susceptibility_to | 0.43399662 |
| 67 | MP0003011_delayed_dark_adaptation | 0.42750310 |
| 68 | MP0005166_decreased_susceptibility_to | 0.42707349 |
| 69 | MP0000566_synostosis | 0.41343873 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.37645633 |
| 71 | MP0003638_abnormal_response/metabolism_ | 0.37107209 |
| 72 | MP0005448_abnormal_energy_balance | 0.36134786 |
| 73 | MP0000639_abnormal_adrenal_gland | 0.34807689 |
| 74 | MP0005647_abnormal_sex_gland | 0.34547229 |
| 75 | MP0000249_abnormal_blood_vessel | 0.31684575 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.30998078 |
| 77 | MP0003075_altered_response_to | 0.29548396 |
| 78 | MP0003953_abnormal_hormone_level | 0.27008752 |
| 79 | MP0009115_abnormal_fat_cell | 0.26769111 |
| 80 | MP0004043_abnormal_pH_regulation | 0.25865637 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 0.25772632 |
| 82 | MP0004272_abnormal_basement_membrane | 0.25291226 |
| 83 | MP0005083_abnormal_biliary_tract | 0.24940934 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.24278140 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.23116127 |
| 86 | MP0002128_abnormal_blood_circulation | 0.22195220 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.20972215 |
| 88 | MP0001851_eye_inflammation | 0.20435165 |
| 89 | MP0004883_abnormal_blood_vessel | 0.19996728 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 0.19394515 |
| 91 | MP0005197_abnormal_uvea_morphology | 0.19032966 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.18327552 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.18327552 |
| 94 | MP0005164_abnormal_response_to | 0.17574621 |
| 95 | MP0002697_abnormal_eye_size | 0.17397415 |
| 96 | MP0002928_abnormal_bile_duct | 0.17172183 |
| 97 | MP0003718_maternal_effect | 0.16885988 |
| 98 | MP0000371_diluted_coat_color | 0.16745082 |
| 99 | MP0002135_abnormal_kidney_morphology | 0.15606277 |
| 100 | MP0001756_abnormal_urination | 0.15578524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.20502734 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 9.17296157 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.76878782 |
| 4 | Abnormality of complement system (HP:0005339) | 8.60436460 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 7.93782435 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.29228237 |
| 7 | Joint hemorrhage (HP:0005261) | 6.38116175 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 6.31853327 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 6.26196336 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.56554663 |
| 11 | Glomerulonephritis (HP:0000099) | 5.43429515 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.16989845 |
| 13 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.16769740 |
| 14 | Xanthomatosis (HP:0000991) | 4.82928562 |
| 15 | Spontaneous abortion (HP:0005268) | 4.56555790 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 4.48249132 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.34327677 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.19078819 |
| 19 | Nephritis (HP:0000123) | 4.07060011 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.89479368 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.86412734 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.61362510 |
| 23 | Neonatal hypoglycemia (HP:0001998) | 3.60731368 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32209232 |
| 25 | Hyperglycinemia (HP:0002154) | 3.24765611 |
| 26 | Fair hair (HP:0002286) | 3.17983386 |
| 27 | Delayed CNS myelination (HP:0002188) | 3.14033292 |
| 28 | Fat malabsorption (HP:0002630) | 3.05849400 |
| 29 | Hypercholesterolemia (HP:0003124) | 2.94063344 |
| 30 | Hyperammonemia (HP:0001987) | 2.92562537 |
| 31 | Epidermoid cyst (HP:0200040) | 2.84822707 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 2.84053313 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.84053313 |
| 34 | Hemorrhage of the eye (HP:0011885) | 2.78228182 |
| 35 | Mitral stenosis (HP:0001718) | 2.77255554 |
| 36 | Gingival bleeding (HP:0000225) | 2.76893894 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.72504224 |
| 38 | Hyperbilirubinemia (HP:0002904) | 2.70672221 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.65926113 |
| 40 | Thrombophlebitis (HP:0004418) | 2.63866040 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.60212825 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.56906217 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.55616120 |
| 44 | Osteomalacia (HP:0002749) | 2.53644752 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.51146959 |
| 46 | Vascular calcification (HP:0004934) | 2.39612624 |
| 47 | Rickets (HP:0002748) | 2.37603728 |
| 48 | Hyperglycinuria (HP:0003108) | 2.30153885 |
| 49 | Menorrhagia (HP:0000132) | 2.26352779 |
| 50 | Generalized hypopigmentation of hair (HP:0011358) | 2.25083981 |
| 51 | Purpura (HP:0000979) | 2.23917016 |
| 52 | Pulmonary embolism (HP:0002204) | 2.22523817 |
| 53 | Cholelithiasis (HP:0001081) | 2.20887274 |
| 54 | Ketosis (HP:0001946) | 2.13955080 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.12638320 |
| 56 | Steatorrhea (HP:0002570) | 2.11570518 |
| 57 | Elevated alkaline phosphatase (HP:0003155) | 2.06540497 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.04843092 |
| 59 | Blue irides (HP:0000635) | 2.03874857 |
| 60 | Complement deficiency (HP:0004431) | 10.7029221 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.4813972 |
| 62 | Metabolic acidosis (HP:0001942) | 1.97260328 |
| 63 | Enlarged kidneys (HP:0000105) | 1.95886861 |
| 64 | Arthropathy (HP:0003040) | 1.93947038 |
| 65 | Hypophosphatemic rickets (HP:0004912) | 1.91418760 |
| 66 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88998016 |
| 67 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85962667 |
| 68 | Myocardial infarction (HP:0001658) | 1.83971369 |
| 69 | Increased mean platelet volume (HP:0011877) | 1.80804130 |
| 70 | Cerebral palsy (HP:0100021) | 1.76499706 |
| 71 | Impaired platelet aggregation (HP:0003540) | 1.72135104 |
| 72 | Abnormal platelet function (HP:0011869) | 1.72135104 |
| 73 | Skin nodule (HP:0200036) | 1.71988958 |
| 74 | Joint swelling (HP:0001386) | 1.70817381 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 1.70202559 |
| 76 | Epistaxis (HP:0000421) | 1.69118826 |
| 77 | Increased serum ferritin (HP:0003281) | 1.68101043 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 1.66370574 |
| 79 | Hyperphosphaturia (HP:0003109) | 1.66310630 |
| 80 | Cholecystitis (HP:0001082) | 1.66196613 |
| 81 | Abnormal gallbladder physiology (HP:0012438) | 1.66196613 |
| 82 | Poikilocytosis (HP:0004447) | 1.65689577 |
| 83 | Abnormality of vitamin metabolism (HP:0100508) | 1.65553937 |
| 84 | Abnormal platelet volume (HP:0011876) | 1.62711523 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 1.61973962 |
| 86 | Irritability (HP:0000737) | 1.60104639 |
| 87 | Reticulocytosis (HP:0001923) | 1.55101448 |
| 88 | Esophageal varix (HP:0002040) | 1.54850645 |
| 89 | Atrioventricular block (HP:0001678) | 1.54422066 |
| 90 | Abnormality of the Achilles tendon (HP:0005109) | 1.53578362 |
| 91 | Glycosuria (HP:0003076) | 1.53233999 |
| 92 | Abnormality of urine glucose concentration (HP:0011016) | 1.53233999 |
| 93 | Gangrene (HP:0100758) | 1.52527974 |
| 94 | Gout (HP:0001997) | 1.51930272 |
| 95 | Bifid scrotum (HP:0000048) | 1.51687965 |
| 96 | Abnormality of purine metabolism (HP:0004352) | 1.50956118 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.50716652 |
| 98 | Abnormal biliary tract physiology (HP:0012439) | 1.49787911 |
| 99 | Bile duct proliferation (HP:0001408) | 1.49787911 |
| 100 | Abnormal delivery (HP:0001787) | 1.48984408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.15264519 |
| 2 | PIK3CG | 4.14963967 |
| 3 | MST1R | 3.78502921 |
| 4 | ACVR1B | 3.76064590 |
| 5 | SIK1 | 3.23732817 |
| 6 | FGFR4 | 3.22382219 |
| 7 | FRK | 2.83840749 |
| 8 | WNK4 | 2.47325624 |
| 9 | TRIB3 | 2.47064434 |
| 10 | PKN2 | 2.20076049 |
| 11 | TYK2 | 2.19613874 |
| 12 | BMPR1B | 2.14339883 |
| 13 | NTRK3 | 1.97081047 |
| 14 | RIPK1 | 1.87798267 |
| 15 | PRKAA2 | 1.86877858 |
| 16 | PRKACG | 1.84447920 |
| 17 | PIK3CA | 1.82066765 |
| 18 | MET | 1.79449455 |
| 19 | BCKDK | 1.73614542 |
| 20 | TNK2 | 1.69699840 |
| 21 | TIE1 | 1.68632313 |
| 22 | TAOK3 | 1.68246164 |
| 23 | EPHA3 | 1.65042937 |
| 24 | INSRR | 1.64431316 |
| 25 | AKT3 | 1.54851140 |
| 26 | MAP2K4 | 1.51859056 |
| 27 | NLK | 1.49768853 |
| 28 | MAPK11 | 1.42104029 |
| 29 | IGF1R | 1.36003986 |
| 30 | FER | 1.35851867 |
| 31 | ERBB2 | 1.34448015 |
| 32 | JAK1 | 1.29299668 |
| 33 | PRKCG | 1.15759031 |
| 34 | CSF1R | 1.14100237 |
| 35 | RET | 0.93644159 |
| 36 | TNIK | 0.93473264 |
| 37 | PDPK1 | 0.91875620 |
| 38 | FGFR3 | 0.91223749 |
| 39 | PDK1 | 0.87898814 |
| 40 | JAK2 | 0.87245948 |
| 41 | PRPF4B | 0.87029457 |
| 42 | BLK | 0.86764506 |
| 43 | MAP3K13 | 0.85974440 |
| 44 | PDK2 | 0.84154203 |
| 45 | PRKAA1 | 0.84037802 |
| 46 | MAP3K3 | 0.83317271 |
| 47 | PRKACA | 0.79100466 |
| 48 | PRKG1 | 0.78123527 |
| 49 | PRKCZ | 0.78123439 |
| 50 | ICK | 0.77884191 |
| 51 | MELK | 0.76141619 |
| 52 | MUSK | 0.74381163 |
| 53 | DAPK2 | 0.71254631 |
| 54 | NME1 | 0.69223929 |
| 55 | FLT3 | 0.66514712 |
| 56 | TGFBR1 | 0.66511189 |
| 57 | TGFBR2 | 0.66136397 |
| 58 | SGK2 | 0.64712453 |
| 59 | MAPK7 | 0.63715808 |
| 60 | PRKACB | 0.62852882 |
| 61 | KDR | 0.61460300 |
| 62 | EPHB1 | 0.60112963 |
| 63 | CAMK1D | 0.58817264 |
| 64 | SGK1 | 0.58687876 |
| 65 | EPHA4 | 0.58567391 |
| 66 | MAP4K2 | 0.57072587 |
| 67 | RPS6KA3 | 0.52451640 |
| 68 | MAP3K7 | 0.51750718 |
| 69 | MAP2K6 | 0.50978597 |
| 70 | MAP3K6 | 0.50743981 |
| 71 | LATS1 | 0.50483712 |
| 72 | MAP3K1 | 0.47477292 |
| 73 | PRKCB | 0.46655779 |
| 74 | MAPK12 | 0.45650674 |
| 75 | MTOR | 0.45304436 |
| 76 | SGK223 | 0.44869234 |
| 77 | SGK494 | 0.44869234 |
| 78 | NEK9 | 0.44839516 |
| 79 | PRKCA | 0.44295688 |
| 80 | SGK3 | 0.43991783 |
| 81 | KIT | 0.41202324 |
| 82 | CAMKK2 | 0.41018386 |
| 83 | ADRBK1 | 0.40621098 |
| 84 | NEK1 | 0.38367088 |
| 85 | SRC | 0.37694398 |
| 86 | MAPK4 | 0.35450164 |
| 87 | CSNK1D | 0.35201788 |
| 88 | CAMK4 | 0.35010145 |
| 89 | CSNK1E | 0.34609018 |
| 90 | MYLK | 0.34310049 |
| 91 | CAMKK1 | 0.32881272 |
| 92 | MAPK3 | 0.32293134 |
| 93 | WNK1 | 0.31858288 |
| 94 | NTRK1 | 0.31767966 |
| 95 | MAP2K1 | 0.30465324 |
| 96 | GSK3A | 0.29707905 |
| 97 | WNK3 | 0.29626086 |
| 98 | CSNK1A1 | 0.29086654 |
| 99 | MAPK1 | 0.27536342 |
| 100 | CAMK1G | 0.26332435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.69304347 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.64817843 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.90033213 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.66922660 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.57434797 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.43408929 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10903312 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.93270603 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.87965666 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.76460806 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67352068 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59572359 |
| 13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.54235991 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.53874276 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.42773413 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35033022 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.29248741 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.15732648 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.12515390 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03155946 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92241994 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.90438582 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.70824326 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.56268239 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55427950 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53877045 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43144875 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41709842 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38928153 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.38815978 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31710724 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30791309 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.27182513 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26691003 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19264680 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18828698 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17312239 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15027745 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.11956273 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.00217759 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99240769 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97090753 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96567646 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92632430 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90066193 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85131987 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84766217 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76716812 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75652432 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71951061 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66398170 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62193274 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61522293 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52636049 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47792466 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.45820417 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40181001 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.32271104 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29907403 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27551034 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.27407864 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23919979 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23428303 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20990064 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18984192 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15717718 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14008955 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12049332 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11451206 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.10776116 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.07206567 |
| 72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04749238 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.04431566 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.00832607 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00344574 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2699278 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.2678515 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2633028 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2520769 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2376657 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2188159 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2131156 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1972238 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1356531 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1299010 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.1272374 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1169701 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1155948 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1108844 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1106805 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1010998 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0967490 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0960937 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0838238 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0642934 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0574781 |
| 97 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0547961 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0362784 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0216855 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0101137 |

